Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies

/in , /da

Autore: Rosaria Del Giorno . Stephen Skaper . Antonella Paladini . Giustino Varrassi . Stefano Coaccioli

Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies

Potrebbero interessarti
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-a
Increased Expression of Pattern Recognition Receptors and Nitric Oxide Synthase in Patients with Endometriosis
L’impiego di L-acetil-carnitina nel dolore neuropatico e nel mixed pain
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis
Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine
The Basal Pharmacology of Palmitoylethanolamide